Total Payments
$47,338
2024 Payments
$15,748
Companies
29
Transactions
188
Medicare Patients
8,371
Medicare Billing
$10.2M
Payment Breakdown by Category
Consulting$38,059 (80.4%)
Food & Beverage$6,297 (13.3%)
Other$1,939 (4.1%)
Travel$954.10 (2.0%)
Education$87.92 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $38,059 | 13 | 80.4% |
| Food and Beverage | $6,297 | 168 | 13.3% |
| Honoraria | $1,892 | 1 | 4.0% |
| Travel and Lodging | $954.10 | 4 | 2.0% |
| Education | $87.92 | 1 | 0.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $47.36 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EyePoint Pharmaceuticals US, Inc. | $18,706 | 19 | $0 (2024) |
| LEICA MICROSYSTEMS INC. | $15,350 | 4 | $0 (2023) |
| Allergan, Inc. | $3,567 | 16 | $0 (2021) |
| Astellas Pharma US Inc | $3,023 | 12 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $2,299 | 10 | $0 (2024) |
| Genentech USA, Inc. | $1,038 | 26 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,030 | 30 | $0 (2024) |
| Alimera Sciences, Inc. | $547.22 | 25 | $0 (2024) |
| Alcon Vision LLC | $246.89 | 2 | $0 (2023) |
| Spark Therapeutics, Inc. | $233.54 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,748 | 50 | EyePoint Pharmaceuticals US, Inc. ($10,175) |
| 2023 | $2,770 | 36 | LEICA MICROSYSTEMS INC. ($1,000) |
| 2022 | $5,225 | 20 | LEICA MICROSYSTEMS INC. ($4,600) |
| 2021 | $10,174 | 24 | EyePoint Pharmaceuticals US, Inc. ($5,099) |
| 2020 | $10,620 | 11 | LEICA MICROSYSTEMS INC. ($7,150) |
| 2019 | $286.75 | 10 | Novartis Pharmaceuticals Corporation ($131.82) |
| 2018 | $1,883 | 24 | Allergan Inc. ($1,333) |
| 2017 | $630.54 | 13 | Regeneron Healthcare Solutions, Inc. ($156.30) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Ophthalmology | ||||||
| 12/16/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: Ophthalmology | ||||||
| 12/13/2024 | Genentech USA, Inc. | Susvimo (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $0.84 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/25/2024 | Apellis Pharmaceuticals, Inc. | — | Honoraria | Cash or cash equivalent | $1,892.00 | General |
| 11/14/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/05/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: EYE CARE | ||||||
| 10/31/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $30.74 | General |
| Category: Ophthalmology | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $34.88 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $0.52 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/15/2024 | Astellas US LLC | Izervay (Drug) | Food and Beverage | In-kind items and services | $135.72 | General |
| Category: Ophthalmology | ||||||
| 10/10/2024 | Genentech USA, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/07/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 10/04/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/23/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Ophthalmology | ||||||
| 09/18/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 09/10/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $32.06 | General |
| Category: Ophthalmology | ||||||
| 09/03/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $34.41 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/03/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/29/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: EYE CARE | ||||||
| 08/08/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $34.35 | General |
| Category: Ophthalmology | ||||||
| 07/23/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 07/19/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $37.63 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/19/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $0.73 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,002 | 40,254 | $9.1M | $2.5M |
| 2022 | 15 | 1,949 | 15,400 | $11.1M | $2.4M |
| 2021 | 16 | 2,132 | 11,484 | $13.8M | $2.7M |
| 2020 | 19 | 2,288 | 10,855 | $7.1M | $2.6M |
Total Patients
8,371
Total Services
77,993
Medicare Billing
$10.2M
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 145 | 1,414 | $5.3M | $978,633 | 18.3% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 84 | 32,100 | $1.3M | $916,488 | 71.4% |
| J3590 | Unclassified biologics | Office | 2023 | 122 | 667 | $371,269 | $232,735 | 62.7% |
| 67028 | Injection of drug into eye | Office | 2023 | 280 | 1,284 | $652,512 | $118,877 | 18.2% |
| J0179 | Injection, brolucizumab-dbll, 1 mg | Office | 2023 | 14 | 432 | $548,640 | $107,106 | 19.5% |
| 92134 | Imaging of retina | Office | 2023 | 590 | 1,607 | $253,674 | $44,890 | 17.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 290 | 388 | $196,328 | $32,944 | 16.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 229 | 329 | $117,124 | $18,965 | 16.2% |
| J3396 | Injection, verteporfin, 0.1 mg | Office | 2023 | 12 | 1,790 | $80,550 | $15,915 | 19.8% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 12 | 12 | $54,024 | $10,434 | 19.3% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 103 | 104 | $50,648 | $8,290 | 16.4% |
| 67210 | Destruction of growth of retina using a laser | Office | 2023 | 13 | 16 | $32,240 | $6,108 | 18.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 46 | 49 | $21,805 | $4,846 | 22.2% |
| 67221 | Destruction of vascular growth between retina and sclera by photodynamic therapy | Office | 2023 | 12 | 12 | $13,140 | $2,507 | 19.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $15,792 | $2,239 | 14.2% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 12 | 12 | $6,960 | $1,358 | 19.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $6,146 | $1,032 | 16.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 170 | 1,596 | $6.0M | $1.1M | 18.8% |
| J3490 | Unclassified drugs | Office | 2022 | 86 | 352 | $2.5M | $640,160 | 25.9% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 65 | 8,940 | $360,000 | $265,327 | 73.7% |
| J0179 | Injection, brolucizumab-dbll, 1 mg | Office | 2022 | 26 | 600 | $762,000 | $145,330 | 19.1% |
| 67028 | Injection of drug into eye | Office | 2022 | 262 | 1,288 | $659,308 | $120,008 | 18.2% |
| 92134 | Imaging of retina | Office | 2022 | 536 | 1,453 | $229,168 | $40,447 | 17.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 314 | 426 | $215,556 | $37,779 | 17.5% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2022 | 19 | 20 | $94,190 | $17,432 | 18.5% |
About Dr. Robert Sisk, MD
Dr. Robert Sisk, MD is a Ophthalmology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1063614089.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Sisk, MD has received a total of $47,338 in payments from pharmaceutical and medical device companies, with $15,748 received in 2024. These payments were reported across 188 transactions from 29 companies. The most common payment nature is "Consulting Fee" ($38,059).
As a Medicare-enrolled provider, Sisk has provided services to 8,371 Medicare beneficiaries, totaling 77,993 services with total Medicare billing of $10.2M. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Ophthalmology
- Location Cincinnati, OH
- Active Since 06/01/2007
- Last Updated 09/23/2009
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1063614089
Products in Payments
- EYP-1901 (Drug) $10,175
- SURGICAL MICROSCOPES (Device) $9,750
- YUTIQ (Drug) $8,635
- Proveo 8 (Device) $4,600
- Izervay (Drug) $2,937
- Surgical Microscopes (Device) $1,000
- OZURDEX (Drug) $652.60
- Vabysmo (Drug) $476.75
- EYLEA HD (Biological) $458.69
- EYLEA AFLIBERCEPT INJECTION (Biological) $324.19
- Lucentis (Biological) $295.45
- EYLEA (Biological) $288.85
- Syfovre (Drug) $259.21
- Iluvien (Drug) $194.08
- SUSVIMO (Drug) $170.04
- VABYSMO (Drug) $148.37
- ARTEVO 800 (Device) $135.08
- LUXTURNA (Biological) $117.79
- STELLARIS PC (Device) $113.70
- ILUVIEN (Drug) $108.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Cincinnati
Dr. Robert Osher, Md, MD
Ophthalmology — Payments: $1.2M
Ophthalmology $1.2M
Dr. Christopher Riemann, M.d, M.D
Ophthalmology — Payments: $750,272
Ophthalmology $750,272
Dr. Anup Khatana, Md, MD
Ophthalmology — Payments: $418,163
Ophthalmology $418,163
Dr. Michael Snyder, M.d, M.D
Ophthalmology — Payments: $344,869
Ophthalmology $344,869
Dr. Daniel Miller, Md, MD
Ophthalmology — Payments: $99,161
Ophthalmology $99,161
Dr. Hisham Arar, Md, MD
Ophthalmology — Payments: $79,380
Ophthalmology $79,380